Krystexxa and Tacrolimus Extended-Release Tablets
Determining the interaction of Krystexxa and Tacrolimus Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pegloticase
Brand name: Krystexxa
Synonyms: Krystexxa Injection
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Krystexxa-Tacrolimus Granules for Suspension
- Krystexxa-Tacrolimus Injection
- Krystexxa-Tacrolimus Intravenous
- Krystexxa-Tacrolimus oral and injection
- Krystexxa-Tacrolimus Oral, Intravenous
- Krystexxa-Tactinal
- Tacrolimus Extended-Release Tablets-Kurvelo
- Tacrolimus Extended-Release Tablets-Kuvan
- Tacrolimus Extended-Release Tablets-Kuvan (Sapropterin Powder for Oral Solution)
- Tacrolimus Extended-Release Tablets-Kuvan (Sapropterin Tablets)
- Tacrolimus Extended-Release Tablets-Kwell Topical
- Tacrolimus Extended-Release Tablets-Kwellada Lotion 1% Topical